PUMA

academical publication management
collect, organize, and share publications

( en | de )

 

Disambiguation of "Vetma, Vesna"

Author of the publication

copydeleteadd this publication to your clipboard
Phosphoprotein Patterns Predict Trametinib Responsiveness and Optimal Trametinib Sensitisation Strategies in Melanoma

, , , , , , , , , , , , and . Cell Death & Differentiation, 26 (8): 1365-1378 (2019)
DOI: 10.1038/s41418-018-0210-8

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Vetma, Vesna
add a person with the name Vetma, Vesna
 

Other publications of authors with the same name

Phosphoprotein patterns predict trametinib responsiveness and optimal trametinib sensitisation strategies in melanoma, , , , , , , , , and 3 other author(s). Cell Death & Differentiation, (October 2018)Assessment of TRAIL sensitisation by IAP antagonist TL32711 in malignant melanoma and development of a framework for response prediction. Universität Stuttgart, Stuttgart, Dissertation, (2020)Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism, , , , , , , , , and . Cell Death and Differentiation, (2020)Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism, , , , , , , , , and . Cell Death & Differentiation, 27 (8): 2417--2432 (February 2020)Examining the In Vitro Efficacy of the IAP Antagonist Birinapant as a Single Agent or in Combination With Dacarbazine to Induce Melanoma Cell Death, , , , , and . Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 25 (9): 1489--1494 (November 2017)Phosphoprotein Patterns Predict Trametinib Responsiveness and Optimal Trametinib Sensitisation Strategies in Melanoma, , , , , , , , , and 3 other author(s). Cell Death & Differentiation, 26 (8): 1365-1378 (2019)Examining the In Vitro Efficacy of the IAP Antagonist Birinapant as a Single Agent or in Combination With Dacarbazine to Induce Melanoma Cell Death, , , , , and . Oncology research, 25 (9): 1489-1494 (2017)